Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 6/2020

01-06-2020 | Obesity | Original Contributions

Determinants of High Parathyroid Hormone Levels in Patients With Severe Obesity and Their Relationship With the Cardiometabolic Risk Factors, Before and After a Laparoscopic Sleeve Gastrectomy Intervention

Authors: Stefano Ministrini, M. A. Ricci, G. Daviddi, M. Scavizzi, S. De Vuono, M. D’Abbondanza, M. T. Paganelli, M. Boni, A. R. Roscini, A. M. Scarponi, G. Vaudo, G. Lupattelli

Published in: Obesity Surgery | Issue 6/2020

Login to get access

Abstract

Background

Obesity is a risk factor for vitamin D deficiency and hyperparathyroidism. Hyperparathyroidism could exert a negative effect on glucose metabolism and vascular function. The aim of this study was to identify the determinants of hyperparathyroidism beyond vitamin D deficiency, whether hyperparathyroidism could have a negative impact on individual health and whether laparoscopic sleeve gastrectomy (LSG) negatively affects the levels of intact parathyroid hormone (iPTH) and 25(OH) vitamin D (25(OH)D).

Methods

We evaluated the levels of iPTH, 25(OH)D, and leptin, together with markers of insulin sensitivity and early cardiovascular disease, in a cohort of 160 patients with severe obesity before and after an LSG intervention.

Results

Ninety-seven percent of subjects had vitamin D deficiency, and 72% of them had hyperparathyroidism. After correcting for possible confounders, we found a correlation between iPTH levels and carotid intima-media thickness, as well as with the HOMA index. After the LSG, 25(OH)D levels were significantly increased, while iPTH levels were significantly reduced. The reduction of iPTH was significantly correlated with the reduction of BMI, diastolic blood pressure, and leptin, which was the independent predictor of iPTH reduction.

Conclusions

Our results suggest that vitamin D deficiency is not the sole determinant of hyperparathyroidism in severe obesity because visceral fat deposition and leptin could both play a role. Obesity-related hyperparathyroidism is associated with insulin resistance and atherosclerosis, although the results from previous studies were conflicting. Finally, LSG intervention does not negatively affect vitamin D status and improves hyperparathyroidism.
Literature
1.
de Azevedo FR, Caramelli B. Hypovitaminosis D and obesity - coincidence or consequence? Eur Endocrinol. 2013;9(2):128–31.CrossRef
2.
Wei JH, Lee WJ, Chong K, et al. High incidence of secondary hyperparathyroidism in bariatric patients: comparing different procedures. Obes Surg. 2018;28(3):798–804.CrossRef
3.
Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690–3. Erratum in: Am J Clin Nutr. 2003 May;77(5):1342CrossRef
4.
Li J, Byrne ME, Chang E, et al. 1alpha,25-Dihydroxyvitamin D hydroxylase in adipocytes. J Steroid Biochem Mol Biol. 2008;112(1–3):122–6.CrossRef
5.
Targher G, Bertolini L, Scala L, et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2007;17(7):517–24.CrossRef
6.
Kull M, Kallikorm R, Lember M. Body mass index determines sunbathing habits: implications on vitamin D levels. Intern Med J. 2009;39(4):256–8.CrossRef
7.
Aloia JF, Feuerman M, Yeh JK. Reference range for serum parathyroid hormone. Endocr Pract. 2006;12(2):137–44.CrossRef
8.
9.
10.
Pirro M, Manfredelli MR, Helou RS, et al. Association of parathyroid hormone and 25-OH-vitamin D levels with arterial stiffness in postmenopausal women with vitamin D insufficiency. J Atheroscler Thromb. 2012;19(10):924–31.CrossRef
11.
12.
Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease--a review. Eur Heart J. 2004;25(20):1776–87.CrossRef
13.
Palmer M, Adami HO, Bergström R, et al. Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow-up. Lancet. 1987;1(8524):59–62.CrossRef
14.
Hedbäck G, Odén A. Death risk factor analysis in primary hyperparathyroidism. Eur J Clin Investig. 1998;28(12):1011–8.CrossRef
15.
Sawaya RA, Jaffe J, Friedenberg L, et al. Vitamin, mineral, and drug absorption following bariatric surgery. Curr Drug Metab. 2012;13(9):1345.CrossRef
16.
Cole AJ, Beckman LM, Earthman CP. Vitamin D status following bariatric surgery: implications and recommendations. Nutr Clin Pract. 2014;29(6):751–8.CrossRef
17.
Bacci V, Silecchia G. Vitamin D status and supplementation in morbid obesity before and after bariatric surgery. Expert Rev Gastroenterol Hepatol. 2010;4(6):781–94.CrossRef
18.
Chakhtoura MT, Nakhoul N, Akl EA, et al. Guidelines on vitamin D replacement in bariatric surgery: Identification and systematic appraisal. Metabolism. 2016;65(4):586–97.CrossRef
19.
20.
Lemoine S, Guebre-Egziabher F, Sens F, et al. Accuracy of GFR estimation in obese patients. CJASN. 2014;9(4):720–7.CrossRef
21.
Hirooka M, Kumagi T, Kurose K, et al. Technique for the measurement of the visceral fat by ultrasonography: comparison of the measurements by ultrasonography and computed tomography. Intern Med. 2005;44:794–9.CrossRef
22.
23.
Devereux RB. Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods. Hypertension. 1987;9:II9–II26.
24.
Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16(7):713–6.CrossRef
25.
Guglielmi V, Bellia A, Gentileschi P, et al. Parathyroid hormone in surgery-induced weight loss: no glucometabolic effects but potential adaptive response to skeletal loading. Endocrine. 2018;59(2):288–95.CrossRef
26.
Potts JT Jr, Jüppner H. “Diseases of parathyroid glands and calcium homeostasis” in Harrison’s Principles of Internal Medicine. 19th ed. Mc Graw-Hill. 2017.
27.
Friedman J. The long road to leptin. J Clin Invest. 2016;126(12):4727–34.CrossRef
28.
Hoang D, Broer N, Roman SA, et al. Leptin signaling and hyperparathyroidism: clinical and genetic associations. J Am Coll Surg. 2014;218(6):1239–1250.e4.CrossRef
29.
Wang ZV, Scherer PE. Adiponectin, the past two decades. J Mol Cell Biol. 2016;8(2):93–100.CrossRef
30.
Soares MJ, Ping-Delfos WC, Sherriff JL, et al. Vitamin D and parathyroid hormone in insulin resistance of abdominal obesity: cause or effect? Eur J Clin Nutr. 2011;65(12):1348–52.CrossRef
31.
Bellia A, Marinoni G, D’Adamo M, et al. Parathyroid hormone and insulin resistance in distinct phenotypes of severe obesity: a cross-sectional analysis in middle-aged men and premenopausal women. J Clin Endocrinol Metab. 2012;97(12):4724–32.CrossRef
32.
Choi HS, Kim SH, Rhee Y, et al. Serum parathyroid hormone is associated with carotid intima-media thickness in postmenopausal women. Int J Clin Pract. 2008;62(9):1352–7.CrossRef
33.
Jennersjö P, Guldbrand H, Björne S, et al. A prospective observational study of all-cause mortality in relation to serum 25-OH vitamin D3 and parathyroid hormone levels in patients with type 2 diabetes. Diabetol Metab Syndr. 2015;7:53.CrossRef
34.
Bellasi A, Raggi P, Rossi R, et al. Intact parathyroid hormone levels are associated with increased carotid intima media thickness in HIV infected patients. Atherosclerosis. 2014;237(2):618–22.CrossRef
35.
Suwelack B, Gerhardt U, Witta J, et al. Effect of parathyroid hormone levels on carotid intima-media thickness after renal transplantation. Am J Hypertens. 2001;14(10):1012–8.CrossRef
36.
Lee YH, Kweon SS, Choi JS, et al. Association of serum vitamin D and parathyroid hormone with subclinical atherosclerotic phenotypes: The Dong-gu Study. PLoS One. 2017;12(10):e0186421.CrossRef
37.
Hagström E, Ahlström T, Ärnlöv J, et al. Parathyroid hormone and calcium are independently associated with subclinical vascular disease in a community-based cohort. Atherosclerosis. 2015;238(2):420–6.CrossRef
Metadata
Title
Determinants of High Parathyroid Hormone Levels in Patients With Severe Obesity and Their Relationship With the Cardiometabolic Risk Factors, Before and After a Laparoscopic Sleeve Gastrectomy Intervention
Authors
Stefano Ministrini
M. A. Ricci
G. Daviddi
M. Scavizzi
S. De Vuono
M. D’Abbondanza
M. T. Paganelli
M. Boni
A. R. Roscini
A. M. Scarponi
G. Vaudo
G. Lupattelli
Publication date
01-06-2020
Publisher
Springer US
Published in
Obesity Surgery / Issue 6/2020
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04453-z

Other articles of this Issue 6/2020

Obesity Surgery 6/2020 Go to the issue

Original Contributions

Weight Loss and Health Status 5 Years After Adjustable Gastric Banding in Adolescents

Brief Communication

Sleep Duration and Timing in the Medium- to Long-Term Post-Bariatric Surgery

Letter to the Editor

Letter to the Editor Concerning: Petrucciani N, Sebastianelli L, Frey S, Iannelli A. From Nissen Fundoplication to Roux-en-Y Gastric Bypass to Treat Both GERD and Morbid Obesity

Original Contributions

Psychosocial Factors that Inform the Decision to Have Metabolic and Bariatric Surgery Utilization in Ethnically Diverse Patients

Letter to the Editor

The Necessity for Routine Administration of Ursodeoxycholic Acid After Bariatric Surgery

Original Contributions

Long-term Impact of Mini-Gastric Bypass on Inflammatory Cytokines in Cohort of Morbidly Obese Patients: a Prospective Study